Acorah Software Products - Accounts Production 14.6.300 true true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 08377050 Mrs Nicola Connolly iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08377050 2023-01-31 08377050 2024-01-31 08377050 2023-02-01 2024-01-31 08377050 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 08377050 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 08377050 frs-bus:Micro-entities 2023-02-01 2024-01-31 08377050 frs-bus:EntityHasNeverTraded 2023-02-01 2024-01-31 08377050 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 08377050 frs-bus:Director1 2023-02-01 2024-01-31 08377050 2022-01-31 08377050 2023-01-31 08377050 2022-02-01 2023-01-31
Registered number: 08377050
NAD Medical Device Consultancy Limited
Unaudited Financial Statements
For The Year Ended 31 January 2024
James Walsh Accountant Limited
Association of International Accountants
19 Titan Court Laporte Way
Luton
Beds
LU4 8EF
Balance Sheet
Registered number: 08377050
2024 2023
£ £
Current assets 10 10
NET CURRENT ASSETS 10 10
TOTAL ASSETS LESS CURRENT LIABILITIES 10 10
NET ASSETS 10 10
CAPITAL AND RESERVES 10 10

Notes

1. General Information
NAD Medical Device Consultancy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08377050 . The registered office is 19 Titan Court, Laporte Way, Luton, Bedfordshire, LU4 8EF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mrs Nicola Connolly
Director
23rd August 2024